{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:08:57Z","timestamp":1768565337341,"version":"3.49.0"},"posted":{"date-parts":[[2024,6,15]]},"group-title":"Neurology","reference-count":42,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\n                    Mutations within the genes\n                    <jats:italic>PRKN<\/jats:italic>\n                    and\n                    <jats:italic>PINK1<\/jats:italic>\n                    are the leading cause of early onset autosomal recessive Parkinson\u2019s disease (PD). However, the genetic cause of most early-onset PD (EOPD) cases still remains unresolved. Long-read sequencing has successfully identified many pathogenic structural variants that cause disease, but this technology has not been widely applied to PD. We recently identified the genetic cause of EOPD in a pair of monozygotic twins by uncovering a complex structural variant that spans over 7 Mb, utilizing Oxford Nanopore Technologies (ONT) long-read sequencing. In this study, we aimed to expand on this and assess whether a second variant could be detected with ONT long-read sequencing in other unresolved EOPD cases reported to carry one heterozygous variant in\n                    <jats:italic>PRKN<\/jats:italic>\n                    or\n                    <jats:italic>PINK1<\/jats:italic>\n                    .\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    ONT long-read sequencing was performed on patients with one reported\n                    <jats:italic>PRKN\/PINK1<\/jats:italic>\n                    pathogenic variant. EOPD patients with an age at onset younger than 50 were included in this study. As a positive control, we also included EOPD patients who had already been identified to carry two known\n                    <jats:italic>PRKN<\/jats:italic>\n                    pathogenic variants. Initial genetic testing was performed using either short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification (MLPA) for copy number variants.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    48 patients were included in this study (\n                    <jats:italic>PRKN<\/jats:italic>\n                    \u201cone-variant\u201d n = 24,\n                    <jats:italic>PINK1<\/jats:italic>\n                    \u201cone-variant\u201d n = 12,\n                    <jats:italic>PRKN<\/jats:italic>\n                    \u201ctwo-variants\u201d n = 12). Using ONT long-read sequencing, we detected a second pathogenic variant in six\n                    <jats:italic>PRKN<\/jats:italic>\n                    \u201cone-variant\u201d patients (26%, 6\/23) but none in the\n                    <jats:italic>PINK1<\/jats:italic>\n                    \u201cone-variant\u201d patients (0%, 0\/12). Long-read sequencing identified one case with a complex inversion, two instances of structural variant overlap, and three cases of duplication. In addition, in the positive control\n                    <jats:italic>PRKN<\/jats:italic>\n                    \u201ctwo-variants\u201d group, we were able to identify both pathogenic variants in\n                    <jats:italic>PRKN<\/jats:italic>\n                    in all the patients (100%, 12\/12).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\n                    This data highlights that ONT long-read sequencing is a powerful tool to identify a pathogenic structural variant at the\n                    <jats:italic>PRKN<\/jats:italic>\n                    locus that is often missed by conventional methods. Therefore, for cases where conventional methods fail to detect a second variant for EOPD, long-read sequencing should be considered as an alternative and complementary approach.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.06.14.24308784","type":"posted-content","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:50:11Z","timestamp":1718466611000},"source":"Crossref","is-referenced-by-count":0,"title":["The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson\u2019s Disease: a genetic screening study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-9587","authenticated-orcid":false,"given":"Kensuke","family":"Daida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyo","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laksh","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breeana","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rylee","family":"Genner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Masuzugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makito","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kolmogolv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley J","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024062006250734000_2024.06.14.24308784v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X"},{"key":"2024062006250734000_2024.06.14.24308784v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30320-5"},{"key":"2024062006250734000_2024.06.14.24308784v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/33416"},{"key":"2024062006250734000_2024.06.14.24308784v1.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096284"},{"key":"2024062006250734000_2024.06.14.24308784v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005253422103"},{"key":"2024062006250734000_2024.06.14.24308784v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70174-6"},{"key":"2024062006250734000_2024.06.14.24308784v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23031"},{"key":"2024062006250734000_2024.06.14.24308784v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa273"},{"key":"2024062006250734000_2024.06.14.24308784v1.9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2021.12.014","article-title":"Genotype-phenotype correlation of Parkinson\u2019s disease with PRKN variants","volume":"114","year":"2022","journal-title":"Neurobiol Aging"},{"key":"2024062006250734000_2024.06.14.24308784v1.10","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/brain\/awac464","article-title":"Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1\/PRKN-linked Parkinson\u2019s disease","volume":"146","year":"2023","journal-title":"Brain"},{"key":"2024062006250734000_2024.06.14.24308784v1.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f4d832"},{"key":"2024062006250734000_2024.06.14.24308784v1.12","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.neurobiolaging.2020.03.003","article-title":"Comprehensive assessment of PINK1 variants in Parkinson\u2019s disease","volume":"91","year":"2020","journal-title":"Neurobiol Aging"},{"key":"2024062006250734000_2024.06.14.24308784v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab456"},{"key":"2024062006250734000_2024.06.14.24308784v1.14","first-page":"438","article-title":"Structural genomic variations and Parkinson\u2019s disease","volume":"108","year":"2017","journal-title":"Minerva Med"},{"key":"2024062006250734000_2024.06.14.24308784v1.15","doi-asserted-by":"crossref","unstructured":"Daida K , Funayama M , Billingsley KJ , Malik L , Miano-Burkhardt A , Leonard HL , et al. Long-read sequencing resolves a complex structural variant in PRKN Parkinson\u2019s disease. Mov Disord [Internet]. 2023; Available from: https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/mds.29610","DOI":"10.1101\/2023.08.14.23293948"},{"key":"2024062006250734000_2024.06.14.24308784v1.16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.6.745"},{"key":"2024062006250734000_2024.06.14.24308784v1.17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"2024062006250734000_2024.06.14.24308784v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(02)00358-1"},{"key":"2024062006250734000_2024.06.14.24308784v1.19","doi-asserted-by":"crossref","unstructured":"J Billingsley K . Processing frozen human blood samples for population-scale Oxford Nanopore long-read DNA sequencing SOP v1 [Internet]. 2022. Available from: https:\/\/www.protocols.io\/view\/processing-frozen-human-blood-samples-for-populati-b6fhrbj6","DOI":"10.17504\/protocols.io.ewov1n93ygr2\/v1"},{"key":"2024062006250734000_2024.06.14.24308784v1.20","doi-asserted-by":"crossref","unstructured":"Baker B . Processing human frontal cortex brain tissue for population-scale SQK-LSK114 Oxford Nanopore long-read DNA sequencing SOP v1 [Internet]. 2023. Available from: https:\/\/www.protocols.io\/view\/processing-human-frontal-cortex-brain-tissue-for-p-cxkkxkuw","DOI":"10.17504\/protocols.io.kxygx3zzog8j\/v1"},{"key":"2024062006250734000_2024.06.14.24308784v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-02024-y"},{"key":"2024062006250734000_2024.06.14.24308784v1.22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02107-y"},{"key":"2024062006250734000_2024.06.14.24308784v1.23","doi-asserted-by":"crossref","unstructured":"Keskus A , Bryant A , Ahmad T , Yoo B , Aganezov S , Goretsky A , et al. Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads [Internet]. bioRxiv. 2024. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.03.22.24304756.abstract","DOI":"10.1101\/2024.03.22.24304756"},{"key":"2024062006250734000_2024.06.14.24308784v1.24","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/bioinformatics\/bty304","article-title":"AnnotSV: an integrated tool for structural variations annotation","volume":"34","year":"2018","journal-title":"Bioinformatics"},{"key":"2024062006250734000_2024.06.14.24308784v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbs017"},{"key":"2024062006250734000_2024.06.14.24308784v1.26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s43588-022-00387-x","article-title":"Symphonizing pileup and full-alignment for deep learning-based long-read variant calling","volume":"2","year":"2022","journal-title":"Nat Comput Sci"},{"key":"2024062006250734000_2024.06.14.24308784v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603"},{"key":"2024062006250734000_2024.06.14.24308784v1.28","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41592-021-01299-w","article-title":"Haplotype-aware variant calling with PEPPER-Margin-DeepVariant enables high accuracy in nanopore long-reads","volume":"18","year":"2021","journal-title":"Nat Methods"},{"key":"2024062006250734000_2024.06.14.24308784v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2015.25"},{"key":"2024062006250734000_2024.06.14.24308784v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2021.07.005"},{"key":"2024062006250734000_2024.06.14.24308784v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10236"},{"key":"2024062006250734000_2024.06.14.24308784v1.32","doi-asserted-by":"crossref","first-page":"108822","DOI":"10.1016\/j.neuropharm.2021.108822","article-title":"New therapeutic approaches to Parkinson\u2019s disease targeting GBA, LRRK2 and Parkin","volume":"202","year":"2022","journal-title":"Neuropharmacology"},{"key":"2024062006250734000_2024.06.14.24308784v1.33","first-page":"915","article-title":"Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications","volume":"23","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"2024062006250734000_2024.06.14.24308784v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.042"},{"key":"2024062006250734000_2024.06.14.24308784v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv146"},{"key":"2024062006250734000_2024.06.14.24308784v1.36","doi-asserted-by":"crossref","first-page":"fcab197","DOI":"10.1093\/braincomms\/fcab197","article-title":"Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing","volume":"3","year":"2021","journal-title":"Brain Commun"},{"key":"2024062006250734000_2024.06.14.24308784v1.37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13353-015-0282-9","article-title":"Genomic instability in the PARK2 locus is associated with Parkinson\u2019s disease","volume":"56","year":"2015","journal-title":"J Appl Genet"},{"key":"2024062006250734000_2024.06.14.24308784v1.38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.24906","article-title":"Pseudo-heterozygous rearrangement mutation of parkin","volume":"27","year":"2012","journal-title":"Mov Disord"},{"key":"2024062006250734000_2024.06.14.24308784v1.39","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/ene.15788","article-title":"Indication for molecular testing by multiplex ligation-dependent probe amplification in parkinsonism","volume":"30","year":"2023","journal-title":"Eur J Neurol"},{"key":"2024062006250734000_2024.06.14.24308784v1.40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/ane.12538","article-title":"Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson\u2019s disease patients","volume":"134","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"2024062006250734000_2024.06.14.24308784v1.41","doi-asserted-by":"crossref","unstructured":"Diogo D , Wong EHM , DeBoever C , Qu W , Lee J , Crawford S , et al. Estimated genetics prevalence of early-onset Parkinson\u2019s disease caused by PRKN mutations [Internet]. bioRxiv. 2024. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.01.22.24301610.abstract","DOI":"10.1101\/2024.01.22.24301610"},{"key":"2024062006250734000_2024.06.14.24308784v1.42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neures.2020.09.001","article-title":"Parkin-linked Parkinson\u2019s disease: From clinical insights to pathogenic mechanisms and novel therapeutic approaches","volume":"159","year":"2020","journal-title":"Neurosci Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.06.14.24308784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:03:17Z","timestamp":1768507397000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.06.14.24308784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1101\/2024.06.14.24308784","relation":{},"subject":[],"published":{"date-parts":[[2024,6,15]]},"subtype":"preprint"}}